Same-day discharge after joint replacement surgery is feasible in patients with a history of atrial fibrillation (AF), ...

Atrial fibrillation (afib) before age 70 was tied to a 21 percent higher chance of cognitive impairment, a recent study found ...

New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence ...

Atrial fibrillation diagnosed in midlife is linked to a 21% increased risk of dementia at any age and a 36% higher risk of ...

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

Discover how AFib before age 70 increases dementia risk by 21% and early-onset dementia risk by 36%. Learn prevention ...

Abbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation (“PFA”) system to treat patients battling atrial fibrillation (AFib). The development came earlier than expected, ...

Those with AFib have a higher risk of stroke, heart failure, dementia, and early death. Right now, the industry standards ...

Congress, Johnson & Johnson MedTech presented pivotal 12-month safety and effectiveness data from the SmartfIRE study—offering new insights into the future of atrial fibrillation (AFib) treatment. The ...

A COMMON heart rhythm issue increases the risk of developing dementia, scientists have warned. Atrial fibrillation (sometimes called afib or AF) is a type of heart rhythm problem where the heart ...

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...